My latest column is up at RealMoney.

With the stock market flirting with “official” bear market territory, I realized I hadn’t written a bearish piece in a couple of months. Not wanting to buck the trend any longer, I decided to look through the models I follow to see which stocks might be on the pricey side. I think I found one in ACI Worldwide (ACIW) .

ACI develops, markets, installs and supports a broad line of software products and services primarily focused on facilitating electronic payments. The company’s products and services compete with offerings by Fiserv (FISV - Annual Report) , Fidelity National Information Systems (FIS) , S1 Corporation (SONE) , Metavante (MV) , Euronet (EEFT) , Fair Isaac (FIC) , Visa (V) and MasterCard (MA) .

About the only argument one can make in favor of a long position is that the stock has come down a lot — nearly 50% from last July’s peak. Unfortunately, at last July’s peak it had already come down a lot from the prior year’s peak. It is amazing to me that a stock performing so poorly can still be valued as highly as it is. For now, I’m not counting on a reversal in price momentum.

For those of ACI Worldwide’s peers that have earnings on which to base a P/E multiple, the average P/E is about 16. At 16 times the 58-cent current 2009 consensus estimate for ACI Worldwide, the stock would trade at just $9.28 — 46% below the current level. Even at the 21 times multiple S1 enjoys, the downside could be 30%. And those prices assume the company will actually earn what analysts believe it will. As noted earlier, that has not been a safe bet of late.

Disclosure: At time of publication, William Trent has no financial position in the companies mentioned in this article.

My latest column is up at RealMoney. It marks the last of a several part “wallflower” series on stocks with limited analyst coverage on Wall Street.

Standard Parking (STAN) is a leading national provider of parking facility management services. It provides on-site management services at multilevel and surface parking facilities for all major markets of the parking industry. Its properties span 2,100 locations, containing over one million parking spaces, in over 330 cities across the U.S. and Canada.

The company grows both by acquisitions and by winning new contracts. In the first quarter, Standard Parking completed the acquisition of Chicago’s GO Parking. Recent business wins include valet and self-parking services at the Trump International Hotel and Towers in Chicago and the parking operations at five facilities in Queens, New York, by the Greater Jamaica Development Corp.

Furthermore, because the company offers a wide range of services, it can often expand the business opportunities at the locations it acquires. As an example, management noted on the recent earnings conference call that “if it’s a hotel that we’re running, can we run the shuttle to the airport for them, which we just did in a couple cases for some of the hotels that we got in one of the acquisitions.”

With a 46% return on equity and no dividend, the company should be able to sustain its current growth rate in earnings per share by a combination of investing in new growth opportunities and continuing to buy back shares. Even after making an allowance for potential contraction in valuation levels (10 times book value seems a bit steep to me), the stock could return 20% or more annually over the next three to five years.

However, the tiny float makes this a very risky play, as one or more large institutional investors trying to sell would likely flood the market.

Disclosure: At the time of publication, William Trent has no financial position in the companies mentioned in this article.

In the story “Hogan’s Heroes,” Jeffries’ Art Hogan recommended which biotech stock?

Charles River Laboratories (CRL)

“Biotech, especially pharma, outsourcing most of the R&D work that they’re doing, and Charles River’s been the leader in that; the last couple of quarters, they’ve turned the corner here.”

Disclosure: At time of publication, William Trent has no financial position in the companies mentioned in this article.

My latest post is up at RealMoney.

In it, I extend yesterday’s observations about the hidden strength in durable goods orders to specific industries that might benefit. Among those industries were primary metals, computers and electronic products, and motor vehicles and parts.

These industries may prove to be a good starting point for further research.

My latest column is up at RealMoney. In it, I explain why I think the negative reaction to BMC Software’s (BMC) purchase of BladeLogic (BLOG) was overdone. In summary:

BladeLogic is growing nearly 40% annually, compared to just 5% expected growth in BMC next year. By my calculations, it increases BMC’s revenue growth rate by 180 basis points, which should have a significant impact on valuation models.

What’s more, I think there were signs that BMC’s growth was due to accelerate on its own. Deferred revenues had declined slightly over the past nine months, which can act as a drag on revenue growth in future periods. But license sales are up 13.5% so far this year, compared to total growth of less than 9%. Today’s license sales should increase future maintenance and service revenues.

Although the BladeLogic deal is expected to reduce BMC’s 2009 per share earnings by 10 or 11 cents, BMC’s estimates for 2009 had already risen by a similar amount. Effectively, the dilution from BladeLogic offsets BMC’s organic improvements for a year.

Meanwhile, BMC has generated more than $540 million in free cash flow over the last 12 months. Some of that is unsustainable, as it comes from collecting on financed receivables. However, I think the sustainable free cash flow is more than $400 million. That still amounts to a 6.5% free cash flow yield at a time when five-year Treasuries return a paltry 2.2%.

Alternatively, I think the stock can generate double-digit returns over the next few years by virtue of its growth, despite a potential reduction in valuation multiples.

Disclosure: William Trent has no financial position in the companies mentioned.

Last month I wrote about IBM (IBM - Annual Report) and said:

IBM is now trading at a P/E of 12.7x 2008 earnings, compared to a five-year average P/E of nearly 18x. It offers a free cash flow yield of nearly 7% at a time when 5-year Treasuries are yielding 2.8%.Expected long-term earnings growth of 11% annually marks a modest slowdown from the 13% generated over the last five years. It is also well below the sustainable growth rate of 29%, which is further evidence of excess cash flow that can be used for more share repurchases.

Valuation aside, things seem a little dicey here. The new guidance seemed sufficient to spark a better rally than we got. If IBM can’t move when estimates are jacked up by $0.25, what will make it move?

I can’t claim to be expert in technical analysis, but a look at the charts, especially the moving averages, suggests that $109 may be a make-or-break price point for many investors. In today’s market environment, I think I’d rather keep my powder dry than chase a possibly elusive extra four percentage points of upside.

But I’ll be watching. I also might be tempted to find some approach using options. For example, the March $110 call options would provide upside in the event of a strong rally, and could largely be paid for by writing $100 puts. Since I think the valuation is reasonable, being forced to buy at $5 lower wouldn’t hurt my feelings too badly, and I’d still get the exposure to the additional upside if the stock does rally.

$109 did prove to be a make-or-break area, and the effectively zero-cost call option I proposed would be worth almost $6 as of Tuesday’s close. Maybe I should take up technical analysis.

Or maybe I shouldn’t. Given the way some of my fundamental picks (where I do consider myself an expert) are working lately I may be better off sticking with the naive approach.

The following article is a reprint of my February 6, 2008 RealMoney column

Hewitt (HEW) is a leading global provider of human resource benefits, outsourcing and consulting services. On Tuesday the company reported $0.59 in earnings per share, beating analyst estimates by a full $0.20 per share. Given that it currently sports a healthy 9.1% free cash flow yield, I thought it was worth a further look.

Unfortunately, the full year guidance given was that Hewitt is “maintaining our fiscal 2008 guidance despite absorbing what we expect will be about six cents per share in dilution from the divestiture of Cyborg over the balance of the year.” After a $0.20 beat in the first quarter, ideally estimates would be raised by $0.14 (or more) despite absorbing a $0.06 per share dilution.

Hewitt’s surprise was largely driven by the fact that its Human Resources Business Process Outsourcing (HR BPO) business, which accounts for 20% of total revenue, lost less money in the company’s fiscal first quarter 2008 than it did in the prior year. Still, there are contracts that the company is trying to restructure to achieve profitability that are in “sensitive” stages.

Given how much most companies hate the human resources function, one would think that those willing to take on others’ headaches would be able to earn high profits. Unfortunately, there are a surprisingly large number of companies willing to take on those headaches. In the latest 10K, management says that “The principal competitors in our HR BPO segment are technology consultants and integrators such as Accenture (ACN), Affiliated Computer Services (ACS - Annual Report, EDS/ExcellerateHRO (EDS) and IBM (IBM - Annual Report) and; companies that have extended their services into human resources outsourcing such as Automatic Data Processing (ADP) and Convergys (CVG).

On the conference call, management indicated that the outsourcing business was counter-cyclical, with customers outsourcing more in downturns in order to reduce costs. Yet they seemed to contradict this statement by saying that the current market environment was causing their new contract signing pace to be behind schedule. Hewitt’s Zacks rank declined last week from 1 (best) to 2. Although the current rank still puts Hewitt in the top 20% of companies measured for earnings momentum, the cautious guidance and talk of a light pipeline are likely to result in some estimate reductions for the remainder of the year.

Despite the lower sales pipeline and ongoing restructuring of unprofitable contracts, Hewitt paid higher performance-based compensation in the fourth quarter. This resulted in first quarter free cash flow being $4 million lower than last year. The company also expects to spend more on capital expenditures this year, which will dampen free cash flow generation.

Furthermore, while earnings are improving the quality of those earnings is not. To gauge earnings quality, I measured the accrual ratio (change in net operating assets as a percentage of net operating assets) over the past several years. The accrual ratio gives an indication of the extent that earnings are driven by cash flows versus accounting choices. The closer the ratio is to zero, the better. Hewitt’s has been declining.

Source: Zacks Research Wizard, compiled by William A. Trent

So, after looking under the hood, I see a company with falling earnings momentum, falling free cash flow yield and falling earnings quality. The only thing rising in recent quarters has been the share price. As a value oriented investor, I’d rather it was the other way around.

Disclosures: None

Zacks Investment Research has provided Stock Market Beat with a complimentary trial subscription to Research Wizard.

This article is a reprint of my January 31, 2008 RealMoney column.

When International Business Machines (IBM - Annual Report) reported earnings a couple of weeks ago, the consensus among Wall Street’s finest was that the company would earn $7.98 per share in 2008. The company smashed that number, providing guidance of $8.20 to $8.30 per share. Even Papa Bear called it impressive.

The market reacted by enthusiastically doing, well, pretty much nothing. The shares were up a smidge the next day, then dropped back and recovered in line with all the market weirdness. The conference call featured one question after another about the macroeconomic environment.

It’s true that there were some signs that the results were built on a wobbly foundation. Fourth quarter revenues were up 10%, but 6% of that growth was due to currency fluctuations that may or may not reverse next year. If I want to bet on a rising Euro I think I’ll play the currency rather than IBM.

Worse, though short-term global services contracts were up 8%, total contract signings declined 13% compared to the prior year quarter. That means a big drop (25%) in long-term signings, which likely explains why analyst estimates for 2009 only rose by about a nickel after the 2008 guidance hike.

On the bright side, though, the short-term contracts likely mean that the $8.25 guidance midpoint for this year is pretty well in the bag. Since this year is likely the point of maximum economic uncertainty, that is a good thing.

The company also generates plenty of free cash flow, and mostly uses it the way I would want them to. In 2007 IBM generated $16.1 billion in cash from operations, $5.5 billion of which stayed on the balance sheet as increased cash holdings. The company used:

• $18.8 billion to buy back shares,
• $5.0 billion for capital expenditures,
• $2.1 billion for dividends, and
• $1.0 billion for acquisitions.

Debt increased by $12.5 billion, to just over $35 billion. Most of the debt is related to its financing operations. With $16 billion in cash on hand and free cash flow generation of more than $11 billion, I don’t see the debt as a concern at all.

IBM is now trading at a P/E of 12.7x 2008 earnings, compared to a five-year average P/E of nearly 18x. It offers a free cash flow yield of nearly 7% at a time when 5-year Treasuries are yielding 2.8%.

Expected long-term earnings growth of 11% annually marks a modest slowdown from the 13% generated over the last five years. It is also well below the sustainable growth rate of 29%, which is further evidence of excess cash flow that can be used for more share repurchases.

Valuation aside, things seem a little dicey here. The new guidance seemed sufficient to spark a better rally than we got. If IBM can’t move when estimates are jacked up by $0.25, what will make it move?

I can’t claim to be expert in technical analysis, but a look at the charts, especially the moving averages, suggests that $109 may be a make-or-break price point for many investors. In today’s market environment, I think I’d rather keep my powder dry than chase a possibly elusive extra four percentage points of upside.

But I’ll be watching. I also might be tempted to find some approach using options. For example, the March $110 call options would provide upside in the event of a strong rally, and could largely be paid for by writing $100 puts. Since I think the valuation is reasonable, being forced to buy at $5 lower wouldn’t hurt my feelings too badly, and I’d still get the exposure to the additional upside if the stock does rally.

This article was published on RealMoney on February 1, just 4 hours before MicroStrategy surprised investors with a blown earnings report. Although I typically take a long-term view, you can never count on having the luxury to do so.

Looking at my screens this week, I noticed that MicroStrategy’s (MSTR) Zacks rank had jumped from 2 to 1, a rank that puts the company’s earnings revision momentum among the top 5% of companies ranked. Looking further, I found that estimates for both 2007 (yet to be reported) and 2008 had been hiked by more than $0.25 per share in the last 90 days.

Meanwhile, the stock has declined from $110 to $72 during the same period. A declining stock amid rising earnings estimates was something I had to investigate further. Upon doing so, however, my conclusion is that there may still be further downside in the shares.

One thing that has buoyed software stocks in recent years has been the consolidation wave. According to company filings, MicroStrategy “competitors that are primarily focused on business intelligence products include, among others, Actuate (ACTU), Business Objects (BOBJ), Cognos (COGN), Information Builders and the SAS Institute.”

Cognos is being acquired by International Business Machines (IBM - Annual Report) and Business Objects by SAP AG (SAP - Annual Report). Another competitor, Hyperion, was already bought by Oracle. It is increasingly looking like MicroStrategy is among the wallflowers at this dance.

And without an acquisition, things aren’t looking so hot fundamentally. A look at recent customer wins shows a concentration of retail, financial and healthcare markets. Not exactly the clients one wants during a consumer and financial crunch.

Indeed, it looks as though the toll was already being felt when MicroStrategy reported third-quarter results. Although gross accounts receivable were basically flat during the first nine months of 2007, the allowance for doubtful accounts was increased by nearly 50% to $2.8 million. This suggests that the company may be having trouble collecting from some customers.

Both net income and cash flow from operating activities declined during the first nine months of 2007. Though service and maintenance revenue grew, product licenses declined more than 3%. Since customers must license a product before they can service or maintain it, the falling product licenses suggest that profits may continue to fall, especially if customers indeed prefer the convenience of one-stop shopping offered by IBM, Oracle and SAP.

In fact, profits would have been lower still had MicroStrategy expensed all of its software development costs, as it did in early 2006. In the first nine months of 2007 $2.7 million of such costs were capitalized, and the capitalized software balance increased by $1 million. Had the development costs been expensed as incurred, cash from operations would have been $2.7 million (4%) lower and net income would have been $641,000 ($0.05 per share) lower.

The $84 million in free cash flow MicroStrategy generated last year amounts to a 7.5% free cash flow yield. This is more than the 100% premium to Treasuries that I would like to earn from my risky investments. However, the ongoing declines in cash flow mean that I want to be compensated for falling cash flow as well. Each percentage point of expected decline should equate to another percentage point of cash flow yield.

Using the 3% decline in license revenue as a starting point, and the 2.9% Treasury yield as a base, I would want to earn a free cash flow yield of at least 8.8% (2.9 + 2.9 + 3) on MicroStrategy. To get to that yield, the shares would need to fall to $57.

In the meantime, it just looks too risky for me.

Zacks Investment Research has provided Stock Market Beat with a complimentary trial subscription to Research Wizard.

My long-term orientation doesn’t typically fare so well in short term stock picking contests. Nonetheless, I have decided to enter the blogger face-off over at SINLetter. You can check in to see which of us are making the best picks between now and the end of March.

My picks were long SMH, short Diebold (DBD) and long CSG Systems (CSGS).